欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号BE/H/0388/004
药品名称Havrix Junior 720
活性成分
    • Hepatitis A virus, inactivated 720.0 ELISA unit/dos
剂型Suspension for injection in pre-filled syringe
上市许可持有人GlaxoSmithKline Biologicals - SA-NV Rue De L'Institut - 89 1330 - Rixensart - Belgium
参考成员国 - 产品名称Belgium (BE)
Havrix 720 Adult Suspension for injection in pre-filled syringe
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Havrix 720 ELISA vienības/0,5 ml suspensija injekcijām
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
许可日期2024/07/24
最近更新日期2024/10/25
药物ATC编码
    • J07BC02 hepatitis A, inactivated, whole virus
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase